
LUMIDERM AESTHETIC GROUP - EXECUTIVE SUMMARY
===========================================

TARGET: LumiDerm Aesthetic Group, LLC
LOCATION: Scottsdale, AZ (Single-Site)
ANALYSIS DATE: 2025-07-26

BUSINESS PROFILE:
• 6 treatment rooms; 2 injectors (MD + PA), 1 laser tech, 2 estheticians  
• Service Mix: Injectables 65%, Devices 20%, Memberships 10%, Retail 5%
• 100% cash-pay model (no insurance dependency)
• Recent rebrand completed Q4-2024

TTM FINANCIALS (Q3-2024 → Q2-2025):
• Revenue: $6,220,000
• Reported EBITDA: $804,400
• Adjusted EBITDA: $948,400 (15.2% margin)

VALUATION SUMMARY:
• Base Case (8.0x): EV $7,587,200 | Equity $6,337,200
• Valuation Range: $5,388,800 - $7,759,800

LBO ANALYSIS (5-Year Hold):
• Sponsor Equity: $1,896,800
• IRR: 22.3% | MOIC: 2.7x
• Exit Strategy: 7.5x multiple (conservative)

EPV SANITY CHECK:
• EPV Enterprise: $4,776,200
• EPV vs Market: 0.6x (conservative floor)

KEY STRENGTHS:
✓ Strong growth trajectory (consistent quarterly improvement)
✓ Premium Scottsdale market positioning
✓ Cash-pay model reduces collection risk
✓ Recent rebrand positions for continued growth

INVESTMENT HIGHLIGHTS:
✓ Room utilization improvement: 72% → 78% (Q3-24 to Q2-25)
✓ Average ticket growth: $525 → $540
✓ Operational leverage potential on fixed cost base
✓ Geographic expansion opportunity in Phoenix MSA

Generated: July 26, 2025
        